Horizon Therapeutics Public Ltd Co - FORM S-1/A - EX-23.2 - CONSENT OF ERNST & YOUNG LTD. - October 8, 2010

Attached files

file filename
S-1/A - AMENDMENT NO. 2 TO FORM S-1 - Horizon Therapeutics Public Ltd Cods1a.htm
EX-4.10 - INVESTORS' RIGHTS AGREEMENT - Horizon Therapeutics Public Ltd Codex410.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - Horizon Therapeutics Public Ltd Codex231.htm
EX-10.29 - SALES CONTRACT - Horizon Therapeutics Public Ltd Codex1029.htm

Exhibit 23.2

Consent of Ernst & Young Ltd, Independent Auditors

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 24, 2010, with respect to the consolidated financial statements of Nitec Pharma AG included in the Registration Statement (Form S-1) and related Prospectus of Horizon Pharma, Inc. expected to be filed with the Securities and Exchange Commission on or about October 8, 2010.

Ernst & Young Ltd

 

/s/ Jürg Zürcher     /s/ Jörg Schmidt
Jürg Zürcher     Jörg Schmidt
Partner     Senior Manager

Basel, Switzerland

October 8, 2010

Horizon Therapeutics Public Ltd Co Reports